 | • レポートコード：B-GIR08C0334 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、抗レトロウイルス薬の世界市場について調べ、まとめました。種類別セグメントは、多剤併用、NRTI、NNRTI、プロテアーゼ阻害剤、その他等、用途別セグメントは、等に区分しました。抗レトロウイルス薬の世界市場概観、企業動向、企業別抗レトロウイルス薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・抗レトロウイルス薬の市場概観 ・抗レトロウイルス薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・抗レトロウイルス薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・抗レトロウイルス薬の世界市場規模 ・抗レトロウイルス薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・抗レトロウイルス薬のアメリカ市場規模推移 ・抗レトロウイルス薬のカナダ市場規模推移 ・抗レトロウイルス薬のメキシコ市場規模推移 ・抗レトロウイルス薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・抗レトロウイルス薬のドイツ市場規模推移 ・抗レトロウイルス薬のイギリス市場規模推移 ・抗レトロウイルス薬のロシア市場規模推移 ・抗レトロウイルス薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・抗レトロウイルス薬の日本市場規模推移 ・抗レトロウイルス薬の中国市場規模推移 ・抗レトロウイルス薬の韓国市場規模推移 ・抗レトロウイルス薬のインド市場規模推移 ・抗レトロウイルス薬の東南アジア市場規模推移 ・抗レトロウイルス薬の南米市場分析（ブラジル、アルゼンチン等） ・抗レトロウイルス薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・抗レトロウイルス薬の種類別分析/販売量、売上、市場シェア（多剤併用、NRTI、NNRTI、プロテアーゼ阻害剤、その他） ・抗レトロウイルス薬の用途別分析/市場規模（） ・抗レトロウイルス薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・抗レトロウイルス薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Tire-derived fuel (TDF) is composed of shredded scrap tires.
Scope of the Report:
The global Antiretroviral Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Antiretroviral Drug.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Antiretroviral Drug market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Antiretroviral Drug market by product type and applications/end industries.
Market Segment by Companies, this report covers
Gilead Sciences
ViiV Healthcare
Bristol-Myer Squibb
AbbVie
Boehringer-Ingelheim
Johnson and Johnson
Merck
CIPLA
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Multi-Class Drugs Combination
NRTI
NNRTI
Protease Inhibitors
Other
Market Segment by Applications, can be divided into
Hospital
Pharmaceutical Companies
Other
Table of Contents
1 Antiretroviral Drug Market Overview
1.1 Product Overview and Scope of Antiretroviral Drug
1.2 Classification of Antiretroviral Drug by Types
1.2.1 Global Antiretroviral Drug Revenue Comparison by Types (2019-2024)
1.2.2 Global Antiretroviral Drug Revenue Market Share by Types in 2018
1.2.3 Multi-Class Drugs Combination
1.2.4 NRTI
1.2.5 NNRTI
1.2.6 Protease Inhibitors
1.2.7 Other
1.3 Global Antiretroviral Drug Market by Application
1.3.1 Global Antiretroviral Drug Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Pharmaceutical Companies
1.3.4 Other
1.4 Global Antiretroviral Drug Market by Regions
1.4.1 Global Antiretroviral Drug Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Antiretroviral Drug Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Antiretroviral Drug Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antiretroviral Drug Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Antiretroviral Drug Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antiretroviral Drug Status and Prospect (2014-2024)
1.5 Global Market Size of Antiretroviral Drug (2014-2024)
2 Manufacturers Profiles
2.1 Gilead Sciences
2.1.1 Business Overview
2.1.2 Antiretroviral Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Gilead Sciences Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
2.2 ViiV Healthcare
2.2.1 Business Overview
2.2.2 Antiretroviral Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 ViiV Healthcare Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bristol-Myer Squibb
2.3.1 Business Overview
2.3.2 Antiretroviral Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bristol-Myer Squibb Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
2.4 AbbVie
2.4.1 Business Overview
2.4.2 Antiretroviral Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AbbVie Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
2.5 Boehringer-Ingelheim
2.5.1 Business Overview
2.5.2 Antiretroviral Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer-Ingelheim Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
2.6 Johnson and Johnson
2.6.1 Business Overview
2.6.2 Antiretroviral Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson and Johnson Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
2.7 Merck
2.7.1 Business Overview
2.7.2 Antiretroviral Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
2.8 CIPLA
2.8.1 Business Overview
2.8.2 Antiretroviral Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 CIPLA Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
3 Global Antiretroviral Drug Market Competition, by Players
3.1 Global Antiretroviral Drug Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Antiretroviral Drug Players Market Share
3.2.2 Top 10 Antiretroviral Drug Players Market Share
3.3 Market Competition Trend
4 Global Antiretroviral Drug Market Size by Regions
4.1 Global Antiretroviral Drug Revenue and Market Share by Regions
4.2 North America Antiretroviral Drug Revenue and Growth Rate (2014-2019)
4.3 Europe Antiretroviral Drug Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Antiretroviral Drug Revenue and Growth Rate (2014-2019)
4.5 South America Antiretroviral Drug Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Antiretroviral Drug Revenue and Growth Rate (2014-2019)
5 North America Antiretroviral Drug Revenue by Countries
5.1 North America Antiretroviral Drug Revenue by Countries (2014-2019)
5.2 USA Antiretroviral Drug Revenue and Growth Rate (2014-2019)
5.3 Canada Antiretroviral Drug Revenue and Growth Rate (2014-2019)
5.4 Mexico Antiretroviral Drug Revenue and Growth Rate (2014-2019)
6 Europe Antiretroviral Drug Revenue by Countries
6.1 Europe Antiretroviral Drug Revenue by Countries (2014-2019)
6.2 Germany Antiretroviral Drug Revenue and Growth Rate (2014-2019)
6.3 UK Antiretroviral Drug Revenue and Growth Rate (2014-2019)
6.4 France Antiretroviral Drug Revenue and Growth Rate (2014-2019)
6.5 Russia Antiretroviral Drug Revenue and Growth Rate (2014-2019)
6.6 Italy Antiretroviral Drug Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Antiretroviral Drug Revenue by Countries
7.1 Asia-Pacific Antiretroviral Drug Revenue by Countries (2014-2019)
7.2 China Antiretroviral Drug Revenue and Growth Rate (2014-2019)
7.3 Japan Antiretroviral Drug Revenue and Growth Rate (2014-2019)
7.4 Korea Antiretroviral Drug Revenue and Growth Rate (2014-2019)
7.5 India Antiretroviral Drug Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Antiretroviral Drug Revenue and Growth Rate (2014-2019)
8 South America Antiretroviral Drug Revenue by Countries
8.1 South America Antiretroviral Drug Revenue by Countries (2014-2019)
8.2 Brazil Antiretroviral Drug Revenue and Growth Rate (2014-2019)
8.3 Argentina Antiretroviral Drug Revenue and Growth Rate (2014-2019)
8.4 Colombia Antiretroviral Drug Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Antiretroviral Drug by Countries
9.1 Middle East and Africa Antiretroviral Drug Revenue by Countries (2014-2019)
9.2 Saudi Arabia Antiretroviral Drug Revenue and Growth Rate (2014-2019)
9.3 UAE Antiretroviral Drug Revenue and Growth Rate (2014-2019)
9.4 Egypt Antiretroviral Drug Revenue and Growth Rate (2014-2019)
9.5 Nigeria Antiretroviral Drug Revenue and Growth Rate (2014-2019)
9.6 South Africa Antiretroviral Drug Revenue and Growth Rate (2014-2019)
10 Global Antiretroviral Drug Market Segment by Type
10.1 Global Antiretroviral Drug Revenue and Market Share by Type (2014-2019)
10.2 Global Antiretroviral Drug Market Forecast by Type (2019-2024)
10.3 Multi-Class Drugs Combination Revenue Growth Rate (2014-2024)
10.4 NRTI Revenue Growth Rate (2014-2024)
10.5 NNRTI Revenue Growth Rate (2014-2024)
10.6 Protease Inhibitors Revenue Growth Rate (2014-2024)
10.7 Other Revenue Growth Rate (2014-2024)
11 Global Antiretroviral Drug Market Segment by Application
11.1 Global Antiretroviral Drug Revenue Market Share by Application (2014-2019)
11.2 Antiretroviral Drug Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Pharmaceutical Companies Revenue Growth (2014-2019)
11.5 Other Revenue Growth (2014-2019)
12 Global Antiretroviral Drug Market Size Forecast (2019-2024)
12.1 Global Antiretroviral Drug Market Size Forecast (2019-2024)
12.2 Global Antiretroviral Drug Market Forecast by Regions (2019-2024)
12.3 North America Antiretroviral Drug Revenue Market Forecast (2019-2024)
12.4 Europe Antiretroviral Drug Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Antiretroviral Drug Revenue Market Forecast (2019-2024)
12.6 South America Antiretroviral Drug Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Antiretroviral Drug Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Antiretroviral Drug Picture
Table Product Specifications of Antiretroviral Drug
Table Global Antiretroviral Drug and Revenue (Million USD) Market Split by Product Type
Figure Global Antiretroviral Drug Revenue Market Share by Types in 2018
Figure Multi-Class Drugs Combination Picture
Figure NRTI Picture
Figure NNRTI Picture
Figure Protease Inhibitors Picture
Figure Other Picture
Table Global Antiretroviral Drug Revenue (Million USD) by Application (2014-2024)
Figure Antiretroviral Drug Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Pharmaceutical Companies Picture
Figure Other Picture
Table Global Market Antiretroviral Drug Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Antiretroviral Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Antiretroviral Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Antiretroviral Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Antiretroviral Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Antiretroviral Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Antiretroviral Drug Revenue (Million USD) and Growth Rate (2014-2024)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Antiretroviral Drug Type and Applications
Table Gilead Sciences Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
Table ViiV Healthcare Basic Information, Manufacturing Base and Competitors
Table ViiV Healthcare Antiretroviral Drug Type and Applications
Table ViiV Healthcare Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myer Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myer Squibb Antiretroviral Drug Type and Applications
Table Bristol-Myer Squibb Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Antiretroviral Drug Type and Applications
Table AbbVie Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer-Ingelheim Antiretroviral Drug Type and Applications
Table Boehringer-Ingelheim Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson and Johnson Antiretroviral Drug Type and Applications
Table Johnson and Johnson Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Antiretroviral Drug Type and Applications
Table Merck Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
Table CIPLA Basic Information, Manufacturing Base and Competitors
Table CIPLA Antiretroviral Drug Type and Applications
Table CIPLA Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Global Antiretroviral Drug Revenue (Million USD) by Players (2014-2019)
Table Global Antiretroviral Drug Revenue Share by Players (2014-2019)
Figure Global Antiretroviral Drug Revenue Share by Players in 2017
Figure Global Antiretroviral Drug Revenue Share by Players in 2018
Figure Global Top 5 Players Antiretroviral Drug Revenue Market Share in 2018
Figure Global Top 10 Players Antiretroviral Drug Revenue Market Share in 2018
Figure Global Antiretroviral Drug Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Antiretroviral Drug Revenue (Million USD) by Regions (2014-2019)
Table Global Antiretroviral Drug Revenue Market Share by Regions (2014-2019)
Figure Global Antiretroviral Drug Revenue Market Share by Regions (2014-2019)
Figure Global Antiretroviral Drug Revenue Market Share by Regions in 2018
Figure North America Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure Europe Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure South America Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Table North America Antiretroviral Drug Revenue by Countries (2014-2019)
Table North America Antiretroviral Drug Revenue Market Share by Countries (2014-2019)
Figure North America Antiretroviral Drug Revenue Market Share by Countries (2014-2019)
Figure North America Antiretroviral Drug Revenue Market Share by Countries in 2018
Figure USA Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure Canada Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure Mexico Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Table Europe Antiretroviral Drug Revenue (Million USD) by Countries (2014-2019)
Figure Europe Antiretroviral Drug Revenue Market Share by Countries (2014-2019)
Figure Europe Antiretroviral Drug Revenue Market Share by Countries in 2018
Figure Germany Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure UK Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure France Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure Russia Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure Italy Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Antiretroviral Drug Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Antiretroviral Drug Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Antiretroviral Drug Revenue Market Share by Countries in 2018
Figure China Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure Japan Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure Korea Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure India Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Table South America Antiretroviral Drug Revenue by Countries (2014-2019)
Table South America Antiretroviral Drug Revenue Market Share by Countries (2014-2019)
Figure South America Antiretroviral Drug Revenue Market Share by Countries (2014-2019)
Figure South America Antiretroviral Drug Revenue Market Share by Countries in 2018
Figure Brazil Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure Argentina Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure Colombia Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Antiretroviral Drug Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Antiretroviral Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Antiretroviral Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Antiretroviral Drug Revenue Market Share by Countries in 2018
Figure Saudi Arabia Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure UAE Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure Egypt Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure Nigeria Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Figure South Africa Antiretroviral Drug Revenue and Growth Rate (2014-2019)
Table Global Antiretroviral Drug Revenue (Million USD) by Type (2014-2019)
Table Global Antiretroviral Drug Revenue Share by Type (2014-2019)
Figure Global Antiretroviral Drug Revenue Share by Type (2014-2019)
Figure Global Antiretroviral Drug Revenue Share by Type in 2018
Table Global Antiretroviral Drug Revenue Forecast by Type (2019-2024)
Figure Global Antiretroviral Drug Market Share Forecast by Type (2019-2024)
Figure Global Multi-Class Drugs Combination Revenue Growth Rate (2014-2019)
Figure Global NRTI Revenue Growth Rate (2014-2019)
Figure Global NNRTI Revenue Growth Rate (2014-2019)
Figure Global Protease Inhibitors Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Antiretroviral Drug Revenue by Application (2014-2019)
Table Global Antiretroviral Drug Revenue Share by Application (2014-2019)
Figure Global Antiretroviral Drug Revenue Share by Application (2014-2019)
Figure Global Antiretroviral Drug Revenue Share by Application in 2018
Table Global Antiretroviral Drug Revenue Forecast by Application (2019-2024)
Figure Global Antiretroviral Drug Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Pharmaceutical Companies Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Antiretroviral Drug Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Antiretroviral Drug Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Antiretroviral Drug Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Antiretroviral Drug Revenue Market Forecast (2019-2024)
Figure Europe Antiretroviral Drug Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Antiretroviral Drug Revenue Market Forecast (2019-2024)
Figure South America Antiretroviral Drug Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Antiretroviral Drug Revenue Market Forecast (2019-2024)
抗レトロウイルス療法市場：世界及び中国市場分析・予測（～2024年） Antiretroviral Therapy Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Antiretroviral Therapy industry with a focus on the Chinese market. The report provides key statistics on the market status of the Antiretroviral Therapy m…- NSCLC用標的薬物MEK阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drug MEK Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especia…
- NSCLC用標的薬剤VEGFR2阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drug VEGFR2 Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, espe…
- NSCLC用標的薬BRAF阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drug BRAF Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especi…
- ドルテグラビル及び併用薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Dolutegravir and Its Combination Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especial…